Darina Gromyko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Darina Gromyko has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Kristian K. Starheim
CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway
2 shared publications - Thomas Arnesen
Department of Biomedicine, University of Bergen, Bergen, Norway
2 shared publications - D. C. Anderson
Biosciences Division, SRI International, Harrisonburg, VA 22802, USA
1 shared publication - Diane Kagabo
Department of Molecular Biology, University of Bergen, N-5020 Bergen, Norway
1 shared publication - J E Varhaug
Department of Breast and Endocrine Surgery, Haukeland University Hospital, Bergen, Norway
1 shared publication - Jan Erik Varhaug
Avdeling for bryst- og endokrinkirurgi, Haukeland universitetssykehus, 5021 Bergen, Norway
1 shared publication
Latest Publications
- Open Access
- 4 August 2009
- Published by Springer Nature in BMC Proceedings
- Vol. 3 (S6) , S3
Composition and biological significance of the human Nα-terminal acetyltransferases
Protein Nα-terminal acetylation is one of the most common protein modifications in eukaryotic cells, occurring on approximately 80% of soluble human proteins. An increasing number of studies links Nα-terminal acetylation to cell differentiation, cell cycle, cell survival, and cancer. Thus, Nα-terminal acetylation is an essential modification for normal cell function in humans. Still, little is known about the functional role of Nα-terminal acetylation. Recently, the three major human N-acetyltransferase complexes, hNatA, hNatB and hNatC, were identified and characterized. We here summarize the identified N-terminal acetyltransferase complexes in humans, and we review the biological studies on Nα-terminal acetylation in humans and other higher eukaryotes.
- 4 August 2009
- Published by Springer Nature in BMC Proceedings
- Vol. 3 (S6) , S3
Open AccessComposition and biological significance of the human Nα-terminal acetyltransferases
Protein Nα-terminal acetylation is one of the most common protein modifications in eukaryotic cells, occurring on approximately 80% of soluble human proteins. An increasing number of studies links Nα-terminal acetylation to cell differentiation, cell cycle, cell survival, and cancer. Thus, Nα-terminal acetylation is an essential modification for normal cell function in humans. Still, little is known about the functional role of Nα-terminal acetylation. Recently, the three major human N-acetyltransferase complexes, hNatA, hNatB and hNatC, were identified and characterized. We here summarize the identified N-terminal acetyltransferase complexes in humans, and we review the biological studies on Nα-terminal acetylation in humans and other higher eukaryotes.
- Open Access
- 1 January 2009
- Published by Springer Nature in BMC Biochemistry
- Vol. 10 (1) , 15
A novel human NatA Nα-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1)
Protein acetylation is among the most common protein modifications. The two major types are post-translational Nε-lysine acetylation catalyzed by KATs (Lysine acetyltransferases, previously named HATs (histone acetyltransferases) and co-translational Nα-terminal acetylation catalyzed by NATs (N-terminal acetyltransferases). The major NAT complex in yeast, NatA, is composed of the catalytic subunit Naa10p (N alpha acetyltransferase 10 protein) (Ard1p) and the auxiliary subunit Naa15p (Nat1p). The NatA complex potentially acetylates Ser-, Ala-, Thr-, Gly-, Val- and Cys- N-termini after Met-cleavage. In humans, the homologues hNaa15p (hNat1) and hNaa10p (hArd1) were demonstrated to form a stable ribosome associated NAT complex acetylating NatA type N-termini in vitro and in vivo.
- 1 January 2009
- Published by Springer Nature in BMC Biochemistry
- Vol. 10 (1) , 15
Open AccessA novel human NatA Nα-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1)
Protein acetylation is among the most common protein modifications. The two major types are post-translational Nε-lysine acetylation catalyzed by KATs (Lysine acetyltransferases, previously named HATs (histone acetyltransferases) and co-translational Nα-terminal acetylation catalyzed by NATs (N-terminal acetyltransferases). The major NAT complex in yeast, NatA, is composed of the catalytic subunit Naa10p (N alpha acetyltransferase 10 protein) (Ard1p) and the auxiliary subunit Naa15p (Nat1p). The NatA complex potentially acetylates Ser-, Ala-, Thr-, Gly-, Val- and Cys- N-termini after Met-cleavage. In humans, the homologues hNaa15p (hNat1) and hNaa10p (hArd1) were demonstrated to form a stable ribosome associated NAT complex acetylating NatA type N-termini in vitro and in vivo.